We’re pleased to announce that the UK DRI has joined CaSE, the Campaign for Science and Engineering.
CaSE represents over 115 scientific organisations including businesses, universities, professional bodies and research charities, as well as individual scientists and engineers, working in partnership to deliver a clear expert voice on decisions about science and engineering.
I am delighted that we will now be able to work as members of CaSE to share our expertise in the field of neurodegeneration, continue to advocate for collaborative, inclusive research, and build the right environment for our scientists – and all UK science – to thrive. Dr Adrian Ivinson, UK DRI Chief Operating Officer
Dr Adrian Ivinson, Chief Operating Officer of the UK DRI, said:
“I am delighted that the UK Dementia Research Institute (UK DRI) is becoming a member of CaSE. Since our inception in 2017, we have assembled a critical mass of 800+ researchers working to fill the knowledge gap in dementia and find new treatments for the diseases that cause it.
As an organisation, we have championed multidisciplinary, intensely collaborative discovery science from the start. I am delighted that we will now be able to work as members of CaSE to share our expertise in the field of neurodegeneration, continue to advocate for collaborative, inclusive research, and build the right environment for our scientists – and all UK science – to thrive.”
Professor Sarah Main, Executive Director of CaSE, said:
“We are delighted that the UK Dementia Research Institute (UK DRI) have joined CaSE. The Institute is at the forefront of neurodegenerative research in the UK. Their experience and perspective on tackling complex disease through research will be a valuable asset for the growing CaSE membership community. The diversity of our membership from across the research and innovation sector is a source of pride for CaSE, I am thrilled that UK DRI are adding to that richness.
The ground-breaking research conducted by UK DRI, into a range of neurodegenerative disorders that cause dementia, has the potential to transform lives across the country. We look forward to working with them over the coming years, to continue putting science at the heart of the UK’s future.”
Article published: 6 December 2022
Banner image: CaSE
